{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:31:46Z","timestamp":1781620306530,"version":"3.54.5"},"reference-count":83,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: polycystic ovarian syndrome (PCOS) prevails in females in the 18\u201340-year-old age group and varies from 5\u201320% depending on the demographic and diagnostic standards. It is unknown how long passes between the onset of a specific symptom and the appearance of the disease. The three most significant characteristics of PCOS include irregular menstruation, a polycystic ovarian shape found by pelvic ultrasound, and hyperandrogenism, which could possibly delay menarche. This study\u2019s objective was to assess insulin resistance and bone bio-markers\u2019 metabolism-involved characteristics of females with PCOS. Materials and Methods: We present a cross-sectional study carried out on 100 female patients suffering from PCOS and 100 healthy female subjects as a control living in Saudi Arabia in the Al-Madinah Al-Munawara Region between May 2021 and March 2022. The age of the studied groups ranges from 20\u201340 years, and patients were categorized into three groups; group I (control, n = 100), group IIa (overweight or obese females with PCOS, n = 70), and group IIb (non-obese females with PCOS, n = 30). The diagnosis of PCOS was carried out as per Rotterdam criteria as recommended for adolescent and adult subjects. All the groups were subjected to physical examination, and anthropometric measures, biochemical parameters, endocrine activity, and clinical parameters were determined. The data obtained were computerized and analyzed statistically using the SPSS program for range, mean, and standard deviation. ANOVA test with post hoc Tukey test was applied to assess the pattern and variation among the test and control groups. Results: In the present study, age, waist circumstances, systolic blood pressure, and diastolic blood pressure were reported enhanced in the PCOS over the control group. Additionally, anthropometric measures were reported slightly upregulated in group IIa over group IIb (p &lt; 0.001). Biochemical parameters including glucose, insulin incidence, and lipids were reported higher in the PCOS over the control group, where group IIa showed slightly increased values compared to group IIb (p &lt; 0.001). On the contrary, PTH, Ca+2, and 25(OH)D levels were reported lower in the PCOS over the control group. However, in the control groups, a slight variation was reported as higher in group IIa compared to group II. In the study, PTH and 25(OH)D were found associated with bone metabolism; a lower level of PTH and 25 (OH) D is linked with a decline in bone density. Conclusions: Lower serum levels of PINP and osteocalcin along with the 25(OH)D were associated with the PCOS compared to the control group, imposing a higher risk of the syndrome. On the contrary, an elevated level of NTx in groups IIa and IIb over the control group was associated with insulin resistance and bone metabolism.<\/jats:p>","DOI":"10.3390\/medicina59030593","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:33:57Z","timestamp":1679024037000},"page":"593","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insulin Resistance and Bone Metabolism Markers in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study on Females from the Islamic University Medical Center"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-6445","authenticated-orcid":false,"given":"Fahad Khalid","family":"Aldhafiri","sequence":"first","affiliation":[{"name":"Public Health Department, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4958-1761","authenticated-orcid":false,"given":"Fathy Elsayed","family":"Abdelgawad","sequence":"additional","affiliation":[{"name":"Medical Biochemistry Department, Faculty of Medicine, Al-Azhar University, Cairo 11651, Egypt"},{"name":"Chemistry Department, Faculty of Science, Islamic University of Madinah, Madinah 42351, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gihan Mohamed","family":"Mohamed Bakri","sequence":"additional","affiliation":[{"name":"Female Section, University Medical Center, Islamic University of Madinah, Madinah 42351, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-2184","authenticated-orcid":false,"given":"Tamer","family":"Saber","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig 44511, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised (2003) consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome. Fertil. Steril., 81, 19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: Criteria for defi ning polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profi le","volume":"84","author":"Kouli","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwn137","article-title":"A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka","volume":"168","author":"Kumarapeli","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1447-0756.2007.00631.x","article-title":"Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women","volume":"33","author":"Vutyavanich","year":"2007","journal-title":"J. Obs. Gynaecol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum. Reprod."},{"key":"ref_10","first-page":"238","article-title":"The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria","volume":"62","author":"Mehrabian","year":"2011","journal-title":"Endokrynol. Pol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-9-39","article-title":"The prevalence of polycystic ovary syndrome ina community sample of Iranian population: Iranian PCOS prevalence study","volume":"9","author":"Tehrani","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.me.36.020185.002241","article-title":"The molecular mechanism of insulin action","volume":"36","author":"Kahn","year":"1985","journal-title":"Ann. Rev. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1016\/S0021-9258(18)33955-3","article-title":"Insulin stimulation of phosphorylation of the subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine","volume":"257","author":"Kasuga","year":"1982","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1021\/bi00245a010","article-title":"Autophosphorylation within insulinreceptor \u03b1-subunits can occur as an intramolecular process","volume":"30","author":"Shoelson","year":"1991","journal-title":"Biochemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation incultured fi broblasts and in skeletal muscle","volume":"96","author":"Dunaif","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects ininsulin action in polycystic ovary syndrome","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"ref_18","first-page":"577","article-title":"Cellular mechanisms of insulin resistance inpolycystic ovarian syndrome","volume":"75","author":"Ciaraldi","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jcem-64-1-162","article-title":"Relationship of androgenic activity tosplanchnic insulin metabolism and peripheral glucose utilization in premenopausal women","volume":"64","author":"An","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncpendmet0755","article-title":"Cardiometabolic features of polycystic ovary syndrome","volume":"4","author":"Hoffman","year":"2008","journal-title":"Nat. Clin. Pr. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-2006-948308","article-title":"Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome","volume":"114","author":"Hahn","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1373\/clinchem.2005.052761","article-title":"Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome","volume":"51","author":"Panidis","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-07-0188","article-title":"Vitamin D status and parathyroid hormone in obese children before and after weightloss","volume":"157","author":"Reineher","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","article-title":"Metabolic disturbances in non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"111","author":"Zhu","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humupd\/dmz020","article-title":"Negative impact of polycystic ovary syndrome on bone health: A systematic review and meta-analysis","volume":"25","author":"Piovezan","year":"2019","journal-title":"Hum. Reprod. Update"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/030006059802600101","article-title":"Steroid formation in osteoblast-like cells","volume":"26","author":"Saito","year":"1998","journal-title":"J. Int. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1001\/jama.1992.03490170075028","article-title":"Bone gain in young adult women","volume":"268","author":"Recker","year":"1992","journal-title":"JAMA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s007740170029","article-title":"Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome","volume":"19","author":"Topcu","year":"2001","journal-title":"J. Bone Min. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/cen.13456","article-title":"Tapanainen: Bone markers in polycystic ovary syndrome: A multicentre Study","volume":"87","author":"Lingaiah","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","first-page":"108","article-title":"Poly cystic ovaries: A common feature in transvaginal scans of gynecology patients","volume":"13","author":"Bello","year":"2015","journal-title":"Ann. Ibadan Postgrad. Med."},{"key":"ref_39","unstructured":"Jacobs, D.S. (2001). Laboratory Test Handbook, Lexi-Comp."},{"key":"ref_40","unstructured":"US Department of Health and Human Services (2009). Biosafety in Microbiological and Biomedical Laboratories."},{"key":"ref_41","unstructured":"World Health Organization (2004). Laboratory Biosafety Manual, World Health Organization. [3rd ed.]."},{"key":"ref_42","unstructured":"Burtis, C.A., and Ashwood, E.R. (2001). Tietz Fundamentals of Clinical Chemistry, WB Saunders. [5th ed.]."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/000456328702400303","article-title":"Assays for Follicle Stimulating Hormone and Luteinizing Hormone: Guidelines for the Provision of a Clinical Biochemistry Service","volume":"24","author":"Beastall","year":"1987","journal-title":"Ann. Clin. Biochem."},{"key":"ref_44","unstructured":"Clinical and Laboratory Standards Institute (2005). Protection of Laboratory Workers from Occupationally Acquired Infections: Approved Guideline, Clinical and Laboratory Standards Institute. [3rd ed.]. CLSI Document M29-A3."},{"key":"ref_45","first-page":"2342","article-title":"Anti-prolactin (PRL) Autoantibodies Cause Asymptomatic Hyperprolactinemia: Bioassay and Clearance Studies of PRL-immunoglobulin G Complex","volume":"80","author":"Cavaco","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cca.2014.07.030","article-title":"Thrombin-mediated degradation of parathyroid hormone in serum tubes","volume":"437","author":"Straseski","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_47","unstructured":"CLSI (2006). Statistical Quality Control for Quantitative Measurements: Principles and Definitions; Approved Guideline, CLSI. [3rd ed.]. CLSI document C24-A3 [ISBN 1-56238-613-1]."},{"key":"ref_48","unstructured":"NCCLS (2004). Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline, CLSI. [2nd ed.]. NCCLS document EP5-A2 [ISBN 1-56238-542-9]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrcardio.2009.135","article-title":"Vitamin D status and arterial hypertension: A systematic review","volume":"6","author":"Pilz","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrin Metabol."},{"key":"ref_51","unstructured":"Becker, K.L. (2001). Principles and Practice of Endocrinology and Metabolism, Lippincott Williams & Wilkins. [3rd ed.]."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/00912709922007903","article-title":"DHEA and DHEA-S: A review","volume":"39","author":"Kroboth","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM198405033101807","article-title":"Biologic and Clinical Importance of Proinsulin","volume":"310","author":"Robbins","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000184778","article-title":"Clinical utility of sex hormone binding globulin measurement","volume":"45","author":"Pugeat","year":"1996","journal-title":"Horm. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/clinchem\/41.10.1439","article-title":"Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies","volume":"41","author":"Rosenquist","year":"1995","journal-title":"Clin. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-8981(97)00182-4","article-title":"Quantification of the N-terminal propeptide of human procollagen type I (PINP): Comparison of ELISA and RIA with respect to different molecular forms","volume":"269","author":"Jensen","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone resorption: Quantitation of Type 1 collagen cross-linked N-telepeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J. Bone Min. Res."},{"key":"ref_58","unstructured":"NCCLS (2001). Urinalysis and Collection, Transportation, and Preservation of Urine Specimens; Approved Guideline, CLSI. NCCLS document GP16-A (ISBN 1-56238-282-9)."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jacl.2008.06.013","article-title":"National Lipid Association taskforce on non-HDL cholesterol. The importance of non-HDL cholesterol reporting in lipid management [monograph on the Internet]","volume":"2","author":"Blaha","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1210\/jc.2002-030316","article-title":"Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states","volume":"88","author":"Bastard","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/pgmj.2007.057505","article-title":"The role of DXA bone density scans in the diagnosis and treatment of osteoporosis","volume":"83","author":"Blake","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18773\/austprescr.2016.020","article-title":"Bone mineral density: Testing for osteoporosis","volume":"39","author":"Sheu","year":"2016","journal-title":"Aust. Prescr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0971-5916.166527","article-title":"The role of vitamin D in polycystic ovary syndrome","volume":"142","author":"Lin","year":"2015","journal-title":"Indian. J. Med. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.2012.04434.x","article-title":"Vitamin D in the aetiology and management of polycystic ovary syndrome","volume":"77","author":"Thomson","year":"2012","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2337\/dc09-0209","article-title":"Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals","volume":"32","author":"Lu","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"351385","DOI":"10.1155\/2010\/351385","article-title":"Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis","volume":"2010","author":"Alvarez","year":"2010","journal-title":"Int. J. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00776-008-1265-z","article-title":"Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment","volume":"13","author":"Iba","year":"2008","journal-title":"J. Orthop. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1258\/acb.2009.009110","article-title":"Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide","volume":"47","author":"Koivula","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1210\/jc.2015-2957","article-title":"Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women?","volume":"100","author":"Chavassieux","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-014-2646-0","article-title":"PINP as a biological response marker during teriparatide treatment for osteoporosis","volume":"25","author":"Krege","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/EJE-08-0072","article-title":"Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults","volume":"159","author":"Reis","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_74","first-page":"RC04-7","article-title":"Serum Osteocalcin as a Diagnostic Biomarker for Primary Osteoporosis in Women","volume":"9","author":"Singh","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_75","first-page":"814","article-title":"The association of serum osteocalcin with the bone mineral density in post menopausal women","volume":"7","author":"Vs","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_76","first-page":"139","article-title":"Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome","volume":"12","author":"Chitme","year":"2017","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum. Reprod. Update"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2012-3698","article-title":"Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS)","volume":"98","author":"Borruel","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","first-page":"71","article-title":"Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study","volume":"3","author":"Najem","year":"2008","journal-title":"Libyan J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0032-1309006","article-title":"Lean muscle mass in classic or ovulatory PCOS: Association with central obesity and insulin resistance","volume":"120","author":"Mario","year":"2012","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/humrep\/dev073","article-title":"Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome","volume":"30","author":"Sam","year":"2015","journal-title":"Hum. Reprod."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.1.02207","article-title":"Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls","volume":"155","author":"Glintborg","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e100656","DOI":"10.5812\/ijem.100656","article-title":"Effect of Vitamin D Levels on Bone Remodeling in Healthy Women","volume":"18","author":"Nair","year":"2020","journal-title":"Int. J. Endocrinol. Metab."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/3\/593\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:57:10Z","timestamp":1760122630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/3\/593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":83,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["medicina59030593"],"URL":"https:\/\/doi.org\/10.3390\/medicina59030593","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}